BIOSYNERGY INC Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets (Current Period Unaudited)

In USD, except per-share amounts

	Q2 FY2022 As of Oct 31, 2021	Q1 FY2022 As of Jul 31, 2021	Q4 FY2021 As of Apr 30, 2021	Q3 FY2021 As of Jan 31, 2021	Q2 FY2021 As of Oct 31, 2020	Q1 FY2021 As of Jul 31, 2020	Q3 FY2020 As of Jan 31, 2020	Q2 FY2020 As of Oct 31, 2019	Q1 FY2020 As of Jul 31, 2019	Q4 FY2019 As of Apr 30, 2019	Q3 FY2019 As of Jan 31, 2019	Q2 FY2018 As of Oct 31, 2017	Q1 FY2018 As of Jul 31, 2017	Q4 FY2017 As of Apr 30, 2017	Q3 FY2017 As of Jan 31, 2017	Q2 FY2017 As of Oct 31, 2016	Q1 FY2017 As of Jul 31, 2016	Q4 FY2016 As of Apr 30, 2016	Q3 FY2016 As of Jan 31, 2016	Q1 FY2016 As of Jul 31, 2015
Current assets
Cash
Accounts receivable. Trade (net of allowance for doubtful accounts of $500 in October 31, 2021 and April 30, 2021)
Inventories
Prepaid expenses
Total Current Assets
Property, Plant and Equipment
Equipment
Leasehold improvements
Operating Lease - Right of Use Asset
Property, Plant and Equipment, Gross, Ending Balance
Less accumulated depreciation and amortization
Total equipment and leasehold improvements net
Operating Lease Right of Use
Operating Lease Right of Use Asset
Other Assets
Patents less accumulated amortization
Patents pending
Deposits
Deferred tax asset
Total other assets
Assets, Total
Current Liabilities
Accounts payable
State/Federal Income Taxes Payable
Accrued compensation and payroll taxes
Accrued vacation
Other accrued liabilities
Operating lease liability
Total Current Liabilities
Deferred income taxes

Deferred income taxes
Long term Liabilities
Deferred income taxes
Operating Lease Liability
Operating lease – long term
Total long term liabilities
Stockholders’ Equity
Common stock, no par value: 20,000,000 authorized shares issued: 14,935,511 shares outstanding at July 31, 2020 and April 30, 2020
Common stock, no par value: 20,000,000 authorized Shares issued: 14,935,511 shares at October 31, 2021 and April 30, 2021
Receivable from affiliate
Retained earnings
Total Stockholders’ Equity
Liabilities and Equity, Total

Comments